Page 51 - Prostate News Today

News of the king’s treatment came amid a flurry of royal medical news over the past 10 days.

After King Charles III's diagnosis of an enlarge prostate, he was admitted to a hospital in London to undergo a corrective procedure.

A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders.

A 10-year follow up study of nearly 2,500 U.S. men who received prostate cancer treatment will help inform decision making in terms of treatments and side effects for a diverse population.

Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers has found.

Prostate cancer kills an estimated thirty five thousand men each year.With Chicago cubs legend and MLB hall of famer Ryne Sandberg recently announcing his diag

"The prostate is one of the few organs in the body that doesn't stop growing," said Dr. Samuel Eaton, a urologist at The Miriam Hospital.

This study considers the perspectives of primary care physicians (PCPs) and urologists on what facilitates and what creates barriers to active surveillance (AS) care for men with low-risk prostate cancer.

Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoid or delay treatment like surgery or radiation therapy and their life-changing complications.

Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer.